← Eichor
Study identifier: NCT05345015 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

High Frequency RF Current Effects on Muscle Pain and Function

Condition: Transcutaneous Electric Nerve Stimulation · Chronic Low-back Pain · Hamstring Injury  ·  Sponsor: Aristotle University Of Thessaloniki

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this study is to examine the acute and chronic effects of high frequency electrical current transfer (frequently called "TECAR") on pain and functional movement in individuals with a musculoskeletal injury or pain. The participants will be assigned into an experimental or a control group and outcome measures will be measured prior to, after, 24 and 48 hours following a single intervention session (Acute effects) as well as 3 and 6 months after the intervention (chronic effects).

This description comes directly from the study's public registry record.

Talk to the study team

Eleftherios Kellis, Ph.D.  ·  +302310991053  ·  ekellis@phed-sr.auth.gr

Anna Kellis, MSc  ·  +302510240610  ·  anna24kellis@google.com

Always discuss trial participation with your own doctor first.

Locations (2)

Physiotherapy ClinicKavala, GreeceRecruiting
Laboratory of Neuromechanics, Department of Physical Education and Sport Science, Aristotle University of ThessalonikiSerres, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05345015